Concepedia

Yongsheng Liu

YL

11

Publications

178

Citations

10

H-Index

2020

Active since

Affiliations

Uppsala University(Current)

National Research Tomsk State University

Tomsk Polytechnic University

Affibody (Sweden)

KTH Royal Institute of Technology

Yongsheng Liu is an author at Uppsala University specializing in cancer cell biology, oncology, and molecular biology.

ORCID

Top concepts

Publications per year

2020–2024

11

Publications

11

Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab

Yongsheng Liu, Tianqi Xu, Anzhelika Vorobyeva et al. · Cancers · 2023 · 22 citations · Full text

Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3

Maryam Oroujeni, Ekaterina Bezverkhniaia, Tianqi Xu et al. · Pharmaceutics · 2022 · 21 citations · Full text

, , +26

Affibody-Mediated PNA-Based Pretargeted Cotreatment Improves Survival of Trastuzumab-Treated Mice Bearing HER2-Expressing Xenografts

Maryam Oroujeni, Hanna Tano, Anzhelika Vorobyeva et al. · Journal of Nuclear Medicine · 2021 · 20 citations · Full text

Comparative Evaluation of Novel 177Lu-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting

Hanna Tano, Maryam Oroujeni, Anzhelika Vorobyeva et al. · Cancers · 2021 · 19 citations · Full text

Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1

Sergey M. Deyev, Tianqi Xu, Yongsheng Liu et al. · Cancers · 2021 · 17 citations · Full text

Rows per page

1–5 of 11